Ishizaki T, Tawara K
J Pharmacol Exp Ther. 1979 Nov;211(2):331-7.
The relationship between pharmacokinetics and pharmacodynamics was studied in dogs using sotalol as a model. The t 1/2 of this drug (4.30 +/- 0.40 hr) in dogs was longer than that of other beta adrenergic blockers. The renal clearance of the drug (4.21 +/- 0.31 ml/min/kg) was approximately 90% of total plasma clearance together with an extensive fraction excreted unchanged (72 +/- 12% of dose) in urine. Significant beta blockade, assessed by the response to isoproterenol tachycardia, was observed without change in blood pressure during the experiments. The log plasma sotalol concentration correlated significantly with the beta blockade (P less than .001). In an attempt to obtain insight into drug concentration-effect-time data, we applied a theory for correlating the observed kinetic data with the pharmacological effects using the elimination rate constant (beta) and the slope of log concentration-effect relationship (m). The rate of decline of drug effects (Rd) derived from this application agreed well with that actually observed in the effect-time interrelations.
以索他洛尔为模型,在犬类动物中研究了药代动力学与药效学之间的关系。该药物在犬类动物中的半衰期(t1/2)为(4.30±0.40小时),比其他β肾上腺素能阻滞剂的半衰期长。该药物的肾清除率为(4.21±0.31毫升/分钟/千克),约占总血浆清除率的90%,且有大量药物以原形(占剂量的72±12%)经尿液排泄。在实验过程中,通过对异丙肾上腺素所致心动过速的反应评估,观察到显著的β受体阻滞作用,且血压无变化。血浆索他洛尔浓度的对数与β受体阻滞作用显著相关(P<0.001)。为了深入了解药物浓度-效应-时间数据,我们应用了一种理论,使用消除速率常数(β)和对数浓度-效应关系的斜率(m),将观察到的动力学数据与药理效应相关联。由此应用得出的药物效应下降速率(Rd)与效应-时间相互关系中实际观察到的结果吻合良好。